Kopran Ltd
NSE:KOPRAN

Watchlist Manager
Kopran Ltd Logo
Kopran Ltd
NSE:KOPRAN
Watchlist
Price: 154.41 INR 4.51% Market Closed
Market Cap: 7.5B INR

Kopran Ltd
Revenue

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Kopran Ltd
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Kopran Ltd
NSE:KOPRAN
Revenue
₹5.9B
CAGR 3-Years
5%
CAGR 5-Years
7%
CAGR 10-Years
N/A
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Revenue
₹343.1B
CAGR 3-Years
15%
CAGR 5-Years
14%
CAGR 10-Years
16%
Cipla Ltd
NSE:CIPLA
Revenue
₹283.5B
CAGR 3-Years
9%
CAGR 5-Years
9%
CAGR 10-Years
8%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Revenue
₹549.6B
CAGR 3-Years
10%
CAGR 5-Years
11%
CAGR 10-Years
8%
Lupin Ltd
NSE:LUPIN
Revenue
₹247.5B
CAGR 3-Years
16%
CAGR 5-Years
11%
CAGR 10-Years
7%
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Revenue
₹122.5B
CAGR 3-Years
11%
CAGR 5-Years
9%
CAGR 10-Years
7%
No Stocks Found

Kopran Ltd
Glance View

Market Cap
7.5B INR
Industry
Pharmaceuticals

Kopran Ltd. is a holding company, which engages in the manufacturing of pharmaceuticals and related products. The company is headquartered in Mumbai, Maharashtra. The firm is engaged in the business of manufacturing and supplying international formulations (Finished Dosage Form) and active pharmaceutical ingredients (APIs). Its formulation business unit manufactures oral solid dosages and dry powder formulations for both penicillin and non-penicillin-based drugs. Its APIs business unit offers Sterile Cephalosporins and Carbapenems. The company also offers Macrolide, Antibacterial, Anticonvulsant, and Cardiovascular range of drugs. Its product offering includes antibiotics, cardiovascular, antidiabetic, gastrointestinal, pain management, drugs for erectile dysfunction, antiallergics, respiratory, oncology, central nervous system, antiprotozoal, and anthelmintics. Its antibiotics brands include AMPIK 250 / 500, AMPIK SYRUP, and AMYN - 250 / 500. Its cardiovascular brands include CARDIOTEN - 25 / 50 / 100, CADITONE - 3.125 / 6.25 / 12.5 / 25 and KLODIP - 5 / 10.

KOPRAN Intrinsic Value
132.38 INR
Overvaluation 14%
Intrinsic Value
Price

See Also

What is Kopran Ltd's Revenue?
Revenue
5.9B INR

Based on the financial report for Sep 30, 2025, Kopran Ltd's Revenue amounts to 5.9B INR.

What is Kopran Ltd's Revenue growth rate?
Revenue CAGR 5Y
7%

Over the last year, the Revenue growth was -7%. The average annual Revenue growth rates for Kopran Ltd have been 5% over the past three years , 7% over the past five years .

Back to Top